Randomized phase III study of S-1/Oxaliplatin comparing Tegafur-Uracil/Leucovorin in the Adjuvant chemotherapy of Stage IIIb colorectal cancer.

Trial Profile

Randomized phase III study of S-1/Oxaliplatin comparing Tegafur-Uracil/Leucovorin in the Adjuvant chemotherapy of Stage IIIb colorectal cancer.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms ACTS-CC 02
  • Sponsors Taiho Pharmaceutical Company
  • Most Recent Events

    • 07 Jun 2016 Results of safety analysis (n=966) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
    • 30 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top